AI assistant
Sending…
Cue Biopharma, Inc. — Director's Dealing 2021
Feb 12, 2021
34525_dirs_2021-02-12_5b52d621-00a6-4b71-8629-e93b13f83584.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cue Biopharma, Inc. (CUE)
CIK: 0001645460
Period of Report: 2021-02-10
Reporting Person: Suri Anish (President and CSO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-10 | Stock Option (right to buy) | $15.55 | A | 75000 | Acquired | 2031-02-09 | Common Stock (75000) | Direct |
Footnotes
F1: This stock option grant becomes exercisable in eight equal semi-annual installments beginning August 10, 2021.
More from Cue Biopharma, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Regulatory Filings
2026
Jun 3
Regulatory Filings
2026
Jun 3
Board/Management Information
2026
Jun 2
Proxy Solicitation & Information Statement
2026
May 21
Report Publication Announcement
2026
May 14
Interim / Quarterly Report
2026
May 14
Capital/Financing Update
2026
Apr 22
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 13
Regulatory Filings
2026
Apr 7